Special Issue "Probiotics and Prebiotics"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 March 2012).
Interests: probiotics; prebiotics; bifidobacteria; gnotobiology; helicobacter pylori; stomach; atopic dermatitis; gut-brain axis
Special Issues and Collections in MDPI journals
Probiotics are defined as live non-pathogenic bacteria that beneficially affect the host by influencing the microbiota of the digestive tract. Prebiotics, that are usually saccharides and fiber, represent a source of energy being metabolized by the intestinal and probiotic microbiota. In the last several decades, a rapid enlargement in the use of probiotics/prebiotics occurred for prevention and treatment of diseases in medicine, such as diarrhea caused by certain pathogenic bacteria and viruses, Helicobacter pylori infection, and allergy etc. Rigid evidence supporting the efficacy of probiotics/prebiotics in such clinical uses and mechanical studies are now needed in order to firmly establish them in the modern medicine.
Prof. Dr. Yasuhiro Koga
- prevention of diarrhea caused by pathogenic bacteria and viruses
- Helicobacter pylori infection and complications
- inflammatory bowel diseases
- irritable bowel syndrome
- mucosal immunity
- gut-brain axis